4505 EMPEROR BOULEVARD, DURHAM, NC
Market cap: $1.6B (12/18/2025)
Price: $7.41
FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years
Director Retirement - Nancy J. Hutson Steps Down from BioCryst Board
Receives Early Termination of HSR Waiting Period for Acquisition
Reports Third Quarter 2025 Financial Results and Provides Business Update
Material Contracts, Financial Results, Changes in Board, Management or Compensation, Other Events
Transaction Valued at $250 Million to Drive ORLADEYO Sales
Changes in Board, Management or Compensation
Financial Results, Reg. FD
Q3
Q2
Q1
FY 2023
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
Prospectus Filed Pursuant to Rule 425
S-4
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
SEC Staff Correspondence